// App-Quantinova.ai

PB1430 : CAR-T CELL THERAPY FOR PEOPLE WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A COCHRANE SYSTEMATIC REVIEW

Researchers

Presenter

  • Moritz Ernst

Principal Investigators

  • Marius Goldkuhle

  • Mohamed Abd El Aziz

  • Annika Oeser

  • Burcu Besiroglu

  • Julia Caro-Valenzuela

  • Lise Estcourt

  • Ina Monsef

  • Peter Borchmann

  • Nicole Skoetz

Medical Centers

  • Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

  • Haematology/Transfusion Medicine, NHS Blood and Transplant, Oxford, United Kingdom,

  • Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

  • Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

  • Department of Surgery,Mayo Clinic,Rochester, MN,United States

Locations

  • Germany

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A